Double Blind Comparative Study of TAK-875

The purpose of this study is to evaluate the efficacy and safety of treatment with TAK-875 in diabetic patients.

Inclusion Criteria:

• The participant is an outpatient.
• The participant signs and dates a written, informed consent form and any required privacy authorization prior to the initiation of any study procedures.

Exclusion Criteria:

• The participant has any serious cardiac disease, serious cerebrovascular disorder, or any serious pancreatic or hematological disease.
• The participant is considered ineligible for the study for any other reason by the investigator or subinvestigator.